BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 101727)

  • 1. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
    Crawford CG; van Alphen GW; Cook HW; Lands WE
    Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exogenous and endogenous prostacyclin on the contractility of rabbit splenic capsular smooth muscle.
    Simmet T; Förstermann U; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):245-53. PubMed ID: 6995863
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides.
    Graff G; Stephenson JH; Glass DB; Haddox MK; Goldberg ND
    J Biol Chem; 1978 Nov; 253(21):7662-76. PubMed ID: 29900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Can J Physiol Pharmacol; 1978 Apr; 56(2):206-15. PubMed ID: 638873
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerative autoactivation of prostaglandin biosynthesis by PGG2.
    Hemler ME; Graff G; Lands WE
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1325-31. PubMed ID: 105736
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic studies on Prostanoids. XX. Synthesis of stable (+/-)-prostaglandin H1 analogs.
    Sakai K; Inoue K; Amemiya S; Morita A; Kojima K
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1814-9. PubMed ID: 7408058
    [No Abstract]   [Full Text] [Related]  

  • 12. Contractile effects of a PGH2 analog and PGD2 on intrapulmonary vessels.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Am J Physiol; 1978 Feb; 234(2):H139-45. PubMed ID: 623314
    [No Abstract]   [Full Text] [Related]  

  • 13. Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
    Aksoy MO; Harakal C; Smith JB; Stewart GJ; Zerweck CR
    Br J Pharmacol; 1990 Mar; 99(3):461-6. PubMed ID: 2110015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovine maternal and fetal circulatory responses to an endoperoxide analog.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Proc Soc Exp Biol Med; 1982 Oct; 171(1):46-9. PubMed ID: 7145937
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
    Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
    Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
    [No Abstract]   [Full Text] [Related]  

  • 16. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
    Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
    Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effects of 1-iodo-3-aminomethyl-5,6,7,8-tetrahydro-2-naphthol (ONO-3122) and prostaglandin H2 on vasopressin-induced osmotic water flow in toad bladder.
    Marumo F
    Experientia; 1982 Jul; 38(7):828-9. PubMed ID: 6809486
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.